Gene Therapy in Rare Genetic Disorders: Current Progress and Future Perspectives.

Area of Science:

• Genetics
• Molecular Biology
• Medical Research

Background:

• Rare genetic disorders affect millions globally, posing complex clinical challenges.
• Current treatments primarily manage symptoms, not underlying genetic causes.
• Gene therapy presents a novel approach to address these root causes.

Purpose of the Study:

• To review advancements in gene therapy for rare genetic disorders.
• To highlight therapeutic strategies, delivery systems, and clinical outcomes.
• To examine challenges and future directions in the field.

Main Methods:

• Comprehensive literature review of recent gene therapy research.
• Focus on viral vectors and gene-editing technologies like CRISPR.
• Analysis of clinical outcomes, challenges, and ethical considerations.

Main Results:

• Successful gene therapies developed, including Zolgensma and Luxturna.
• Viral vectors and CRISPR-Cas9 show significant therapeutic potential.
• Key challenges include immune responses, gene delivery efficiency, and long-term safety.

Conclusions:

• Gene therapy holds transformative potential for treating rare genetic disorders.
• Recent successes signal a new era in genetic medicine.
• Continued research is crucial for refining delivery, managing immune reactions, and ensuring safety and ethical application.